Toll Free: 1-888-928-9744

Medigen Biotechnology Corporation - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Medigen Biotechnology Corporation - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Medigen Biotechnology Corporation - Product Pipeline Review - 2014', provides an overview of the Medigen Biotechnology Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medigen Biotechnology Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Medigen Biotechnology Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Medigen Biotechnology Corporation's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Medigen Biotechnology Corporation's pipeline products

Reasons to buy

- Evaluate Medigen Biotechnology Corporation's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Medigen Biotechnology Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Medigen Biotechnology Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Medigen Biotechnology Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medigen Biotechnology Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Medigen Biotechnology Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Medigen Biotechnology Corporation Snapshot 5
Medigen Biotechnology Corporation Overview 5
Key Information 5
Key Facts 5
Medigen Biotechnology Corporation - Research and Development Overview 6
Key Therapeutic Areas 6
Medigen Biotechnology Corporation - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Medigen Biotechnology Corporation - Pipeline Products Glance 12
Medigen Biotechnology Corporation - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Medigen Biotechnology Corporation - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Medigen Biotechnology Corporation - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Medigen Biotechnology Corporation - Drug Profiles 17
muparfostat 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AT-301 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
H1N1 Pandemic Flu Vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Enterovirus 71 Vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Medigen Biotechnology Corporation - Pipeline Analysis 22
Medigen Biotechnology Corporation - Pipeline Products by Target 22
Medigen Biotechnology Corporation - Pipeline Products by Route of Administration 23
Medigen Biotechnology Corporation - Pipeline Products by Molecule Type 24
Medigen Biotechnology Corporation - Pipeline Products by Mechanism of Action 25
Medigen Biotechnology Corporation - Recent Pipeline Updates 26
Medigen Biotechnology Corporation - Company Statement 27
Medigen Biotechnology Corporation - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30
List of Tables
Medigen Biotechnology Corporation, Key Information 5
Medigen Biotechnology Corporation, Key Facts 5
Medigen Biotechnology Corporation - Pipeline by Indication, 2014 7
Medigen Biotechnology Corporation - Pipeline by Stage of Development, 2014 8
Medigen Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 9
Medigen Biotechnology Corporation - Partnered Products in Pipeline, 2014 10
Medigen Biotechnology Corporation - Partnered Products/ Combination Treatment Modalities, 2014 11
Medigen Biotechnology Corporation - Phase III, 2014 12
Medigen Biotechnology Corporation - Phase II, 2014 13
Medigen Biotechnology Corporation - Phase I, 2014 14
Medigen Biotechnology Corporation - IND/CTA Filed, 2014 15
Medigen Biotechnology Corporation - Discovery, 2014 16
Medigen Biotechnology Corporation - Pipeline by Target, 2014 22
Medigen Biotechnology Corporation - Pipeline by Route of Administration, 2014 23
Medigen Biotechnology Corporation - Pipeline by Molecule Type, 2014 24
Medigen Biotechnology Corporation - Pipeline Products by Mechanism of Action, 2014 25
Medigen Biotechnology Corporation - Recent Pipeline Updates, 2014 26
Medigen Biotechnology Corporation, Subsidiaries 28 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify